|
Fusion gene ID: 41955 |
FusionGeneSummary for WDYHV1_WISP2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: WDYHV1_WISP2 | Fusion gene ID: 41955 | Hgene | Tgene | Gene symbol | WDYHV1 | WISP2 | Gene ID | 55093 | 8839 |
Gene name | WDYHV motif containing 1 | WNT1 inducible signaling pathway protein 2 | |
Synonyms | C8orf32 | CCN5|CT58|CTGF-L | |
Cytomap | 8q24.13 | 20q13.12 | |
Type of gene | protein-coding | protein-coding | |
Description | protein N-terminal glutamine amidohydrolaseN-terminal Gln amidaseWDYHV motif-containing protein 1nt(Q)-amidaseprotein NH2-terminal glutamine deamidase | WNT1-inducible-signaling pathway protein 2CCN family member 5connective tissue growth factor-like proteinconnective tissue growth factor-related protein 58 | |
Modification date | 20180522 | 20180523 | |
UniProtAcc | Q96HA8 | O76076 | |
Ensembl transtripts involved in fusion gene | ENST00000287387, ENST00000523984, ENST00000517609, ENST00000523356, ENST00000518125, | ENST00000372868, ENST00000372865, ENST00000190983, ENST00000471629, | |
Fusion gene scores | * DoF score | 3 X 3 X 3=27 | 2 X 2 X 2=8 |
# samples | 3 | 2 | |
** MAII score | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(2/8*10)=1.32192809488736 | |
Context | PubMed: WDYHV1 [Title/Abstract] AND WISP2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BLCA | TCGA-ZF-A9RF-01A | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000287387 | ENST00000372868 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
Frame-shift | ENST00000287387 | ENST00000372865 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
Frame-shift | ENST00000287387 | ENST00000190983 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
5CDS-3UTR | ENST00000287387 | ENST00000471629 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
intron-3CDS | ENST00000523984 | ENST00000372868 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
intron-3CDS | ENST00000523984 | ENST00000372865 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
intron-3CDS | ENST00000523984 | ENST00000190983 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
intron-3UTR | ENST00000523984 | ENST00000471629 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
intron-3CDS | ENST00000517609 | ENST00000372868 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
intron-3CDS | ENST00000517609 | ENST00000372865 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
intron-3CDS | ENST00000517609 | ENST00000190983 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
intron-3UTR | ENST00000517609 | ENST00000471629 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
Frame-shift | ENST00000523356 | ENST00000372868 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
Frame-shift | ENST00000523356 | ENST00000372865 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
Frame-shift | ENST00000523356 | ENST00000190983 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
5CDS-3UTR | ENST00000523356 | ENST00000471629 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
intron-3CDS | ENST00000518125 | ENST00000372868 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
intron-3CDS | ENST00000518125 | ENST00000372865 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
intron-3CDS | ENST00000518125 | ENST00000190983 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
intron-3UTR | ENST00000518125 | ENST00000471629 | WDYHV1 | chr8 | 124429172 | + | WISP2 | chr20 | 43355728 | + |
Top |
FusionProtFeatures for WDYHV1_WISP2 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
WDYHV1 | WISP2 |
Mediates the side-chain deamidation of N-terminalglutamine residues to glutamate, an important step in N-end rulepathway of protein degradation. Conversion of the resulting N-terminal glutamine to glutamate renders the protein susceptible toarginylation, polyubiquitination and degradation as specified bythe N-end rule. Does not act on substrates with internal or C-terminal glutamine and does not act on non-glutamine residues inany position. Does not deaminate acetylated N-terminal glutamine.With the exception of proline, all tested second-position residueson substrate peptides do not greatly influence the activity. Incontrast, a proline at position 2, virtually abolishes deamidationof N-terminal glutamine. {ECO:0000250|UniProtKB:Q80WB5}. | May play an important role in modulating bone turnover.Promotes the adhesion of osteoblast cells and inhibits the bindingof fibrinogen to integrin receptors. In addition, inhibitsosteocalcin production. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for WDYHV1_WISP2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for WDYHV1_WISP2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
WDYHV1 | NME1, DCTPP1, HSD17B14, XIAP, NECAB2, JUP, RPIA, SFN, MDFI, HPRT1, CBFA2T2, BLOC1S6, TRIP13, RABAC1, PCBD1, RBBP8, SMN1, COIL, PTS, ACTB, ACTG1, BIRC2, ASL, BLMH, CAPN3, CDA, CDR2, CRYAA, CTH, DAB1, DHPS, EIF2B1, ETV6, FTH1, GMDS, GOLGA2, PRMT1, KCNH1, KRTAP5-9, KRT31, MAGEA11, MIF, PRPS2, PYGM, TRIM27, SIAH1, TNR, VCP, RAD54L, GAS7, STX11, TSC22D1, PNMA1, RBPMS, MTUS2, GNMT, APIP, AMOTL2, TOLLIP, LZTFL1, THAP1, VAC14, SEPT3, TRIM54, NCOA5, KLHL12, PPCDC, C1orf50, CCDC102B, NPL, KRTAP9-2, LZTS2, NT5C1A, ZNF341, KRTAP9-4, KRTAP4-2, LONRF1, PNMA5, EDARADD, AMOT, MARCH10, NUDT14, KCTD1, KRTAP10-7, KRTAP10-5, CCDC184, ZBTB8A, TMEM239, ARFGAP3, SBNO1, TRIM33, ERN1, SHB, NFATC2IP, INPP4A, MTG2, ZNF639, RPS6KA3, PRADC1, TRIM24, ZHX3, PLA2G10, LPP, TRAF2, ZBTB2, NET1, TRMT1, SIX4, EIF4G3, ASPH, NDC80, CEP85, CRTC2, SRRT, HMGCL, HTRA2, KIF2C, R3HDM1, GNPTG, DMXL2, FAM122B, PKP2, NUP35, MTMR4, GFER, QRICH1, PINX1, RIOK1, INPP5K, NUF2, PCCA, AXIN1, LMNA | WISP2 | HDAC1, HDAC3, PRKRIR, CTU2, AMZ2, TRIM68, PITHD1, ICAM1 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for WDYHV1_WISP2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for WDYHV1_WISP2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |